Work

The evaluation of norethindrone, ethinyl estradiol and a GnRh agonist as chemoprevention of ovarian cancer using a newly developed genetically engineered mouse model of ovarian cancer.

Year: 2007

Type: article

Source: Cancer Epidemiology and Prevention Biomarkers

Authors: Iris L. Romero, Helen Kim, Melissa Gilliam, Daniela M. Dinulescu, Ernst Lengyel, Ilyssa O. Gordon

Institutions: Brigham and Women's Hospital, Harvard University, University of Chicago

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2583237579

FWCI:

Cites:

Cited by:

Related to: 10